CiplaQCIL is a state-of-the-art pharmaceutical company manufacturing the latest Anti-malarial (ACTs), Anti-retroviral (ARVs) and Hepatitis medicines. The plant is based in Kampala, Uganda and it is a WHO approved facility; among one of the few in Sub-Saharan Africa. The products are currently exported to 9 African countries with plans to scale to 19 countries.
In addition to being a WHO approved facility, CiplaQCIL’s medicines have been approved by regulatory bodies across Africa including: Kenya, Rwanda, Tanzania, Namibia, Ivory Coast, Ethiopia and several others. Over 98% of CiplaQCIL’s employees are trained and skilled Ugandans in Pharmacy, Tableting and other technical fields.
CiplaQCIL is committed to meeting the health needs of Uganda and Africa by providing access to quality affordable medicines.